{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T10:54:16Z","timestamp":1772967256715,"version":"3.50.1"},"reference-count":206,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1597,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1365-2036.2011.04658.x","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T00:49:42Z","timestamp":1303174182000},"page":"1273-1291","source":"Crossref","is-referenced-by-count":44,"title":["Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis"],"prefix":"10.1111","volume":"33","author":[{"given":"E. L.","family":"Culver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. W.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4,18]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3748\/wjg.14.3350","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"14","author":"Chapman","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/gut.27.1.86","article-title":"Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis","volume":"27","author":"Chapman","year":"1986","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2214\/ajr.179.2.1790399","article-title":"MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography","volume":"179","author":"Vitellas","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR Cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2559.1991.tb00046.x","article-title":"The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis","volume":"19","author":"Harrison","year":"1991","journal-title":"Histopathology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broome","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bjornsson","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthardt","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB17|cit17","doi-asserted-by":"crossref","DOI":"10.1002\/hep.21960","article-title":"Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis","volume":"47","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1034\/j.1600-0641.2000.033004537.x","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/jhep.2002.37200","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bjornsson","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin-4 associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jhep.2009.05.032","article-title":"Ulcerative colitis associated with IgG4 cholangitis: similar features in two HLA identical siblings","volume":"51","author":"Dastis","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s10620-010-1287-1","article-title":"IgG(4)-related sclerosing disease: a novel mimic of inflammatory bowel disease","volume":"55","author":"Narula","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1440-1746.2010.06411.x","article-title":"Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma","volume":"25","author":"Oh","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","article-title":"Identification and characterization of IgG4-associated autoimmune hepatitis","volume":"30","author":"Chung","year":"2010","journal-title":"Liver Intern"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cgh.2007.12.020","article-title":"Rituximab therapy for refractory biliary strictures in immunoglobulin G4 associated cholangitis","volume":"6","author":"Topazian","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4065\/75.7.688","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.510290607","article-title":"The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis","volume":"29","author":"Kim","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/hep.22178","article-title":"Mortality attributable to cholestatic liver disease in the United States","volume":"47","author":"Mendes","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver diseases","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/01635589809514689","article-title":"Different bile acids exhibit distinct biological effects: the tumour promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation","volume":"31","author":"Martinez","year":"1998","journal-title":"Nutr Cancer"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(90)90281-U","article-title":"Ursodeoxycholic acid for primary sclerosing cholangitis","volume":"11","author":"Chazouilleres","year":"1990","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/hep.1840140516","article-title":"Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study","volume":"14","author":"O\u2019Brien","year":"1991","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365529409103626","article-title":"Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis","volume":"204","author":"Stiehl","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo primary sclerosing cholangitis-ursodeoxycholic acid study group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicentre, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2007.12.023","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective","volume":"48","author":"Cullen","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB52|cit52","first-page":"133","article-title":"Randomized, double-blind controlled trial of high-dose ursodeoxycholic acid for primary sclerosing cholangitis","volume":"47","author":"Lindor","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.510260102","article-title":"Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductile fragments and isolated perfused rat liver","volume":"26","author":"Beneditti","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","article-title":"The impact of ursodeoxycholic acid cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis","volume":"22","author":"Wolf","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MEG.0b013e3281108068","article-title":"The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid","volume":"19","author":"Rudolph","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.22891","article-title":"Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr\u2212\/\u2212 mice","volume":"49","author":"Halilbasic","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/hep.22969","article-title":"Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis","volume":"49","author":"Glaser","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2036.2005.02407.x","article-title":"Review article: current management of primary sclerosing cholangitis","volume":"21","author":"Cullen","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"AASLD practice guidelines: diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolph","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-2002-35298","article-title":"Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis","volume":"34","author":"Lindberg","year":"2002","journal-title":"Endoscopy"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB69|cit69","first-page":"2000","article-title":"Endoscopic management of primary sclerosing cholangitis: review, and report of an open series","volume":"88","author":"Gaing","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5107(91)70618-4","article-title":"Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment","volume":"37","author":"Johnson","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB72|cit72","first-page":"261","article-title":"Endoscopic therapy for primary sclerosing cholangitis: report of an ongoing series","volume":"38","author":"Gaing","year":"1992","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","article-title":"Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis: an 8-year prospective study","volume":"26","author":"Stiehl","year":"1997","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0016-5107(96)70167-0","article-title":"Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclersosing cholangitis","volume":"44","author":"van Milligen de Wit","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB77|cit77","first-page":"155","article-title":"Long-term outcome of percutaneous transhepatic drainage for benign bile duct stenoses","volume":"50","author":"Eickhoff","year":"2005","journal-title":"Rocz Akad Med Bialymst"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00000658-199803000-00014","article-title":"Primary sclerosing cholangitis: resect, dilate, or transplant?","volume":"227","author":"Ahrendt","year":"1998","journal-title":"Ann Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.510300101","article-title":"Primary sclerosing cholangitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0039-6060(05)80078-9","article-title":"Primary sclerosing cholangitis: liver transplantation or biliary surgery","volume":"117","author":"Farges","year":"1995","journal-title":"Surgery"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB81|cit81","first-page":"3574","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis","volume":"26","author":"Muiesan","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.1840220213","article-title":"Liver transplant for sclerosing cholangitis","volume":"22","author":"Narumi","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yasu.2009.02.015","article-title":"Primary sclerosing cholangitis: the role of extrahepatic biliary resection","volume":"43","author":"Tsai","year":"2009","journal-title":"Adv Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jamcollsurg.2007.12.015","article-title":"Primary sclerosing cholangitis: role of extrahepatic biliary resection","volume":"206","author":"Pawlick","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00000658-198805000-00016","article-title":"Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis","volume":"207","author":"Cameron","year":"1988","journal-title":"Ann Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archsurg.1994.01420340071012","article-title":"Surgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approach","volume":"129","author":"Myburgh","year":"1994","journal-title":"Arch Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","article-title":"The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis","volume":"18","author":"Pohl","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.gie.2010.02.043","article-title":"Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis","volume":"72","author":"Negm","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOG.0b013e3282f9e239","article-title":"An update on primary sclerosing cholangitis","volume":"24","author":"Maggs","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3109\/00365529709011222","article-title":"Survival and risk of cholangiocarcinoma in patients with primary sclersosing cholangitis. A population based study","volume":"32","author":"Kornfeld","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0016-5085(87)90618-4","article-title":"Improved survival with primary sclersosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients","volume":"92","author":"Helzberg","year":"1987","journal-title":"Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2006-933562","article-title":"Primary sclerosing cholangitis and cholangiocarcinoma","volume":"26","author":"Lazaridis","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MCG.0b013e31806daf89","article-title":"Cholangiocarcinoma: natural history, treatment and strategies for surveillance in high risk patients","volume":"42","author":"Yachimski","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1034\/j.1600-0641.2000.033004520.x","article-title":"Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.1840120421","article-title":"Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study of 65 patients with bile duct strictures","volume":"12","author":"Rabinovitz","year":"1990","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytological techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A comparison of routine cytology and fluorescence in situ hybridisation for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB106|cit106","first-page":"350","article-title":"The clinical utility of the CA 19-9 tumor-associated antigen","volume":"85","author":"Steinberg","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1572-0241.2003.04006.x","article-title":"EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology","volume":"99","author":"Fritscher-Ravens","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.gie.2007.07.018","article-title":"EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma","volume":"67","author":"Gleeson","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1155\/2010\/704759","article-title":"Cholangiocarcinoma: has there been any progress","volume":"24","author":"Meza-Junco","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1072-7515(98)00207-5","article-title":"Treatment of hilar cholangiocarcinoma (Klatskin tumours) with hepatic resection or transplantation","volume":"187","author":"IIwatsuki","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.surg.2006.01.010","article-title":"Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?","volume":"140","author":"Hemibach","year":"2006","journal-title":"Surgery"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2007.07.003","article-title":"Cholangiocarcinoma: is transplantation an option? For whom?","volume":"47","author":"Gores","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for non-resectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cgh.2007.12.004","article-title":"Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy","volume":"6","author":"Kahaleh","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2214\/ajr.150.3.571","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"150","author":"Brandt","year":"1988","journal-title":"Am J Roentgenol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.pas.0000213435.99492.8a","article-title":"Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for metaplasia-dysplasia-carcinoma sequence","volume":"31","author":"Lewis","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1445-2197.2007.04059.x","article-title":"Gallbladder polyps in sclerosing cholangitis: does the 1\u2003cm rule apply?","volume":"77","author":"Leung","year":"2007","journal-title":"ANZ J Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"Beuers","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"ASSLD practice guidelines: management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.510290450","article-title":"The pruritis of cholestasis","volume":"29","author":"Jones","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0016-5085(80)90149-3","article-title":"Beneficial effects of cholestyramine in sclersosing cholangitis","volume":"79","author":"Polter","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for the treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile acid binding agents, opioid antagonists or rifampicin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB132|cit132","first-page":"1196","article-title":"Ondansetron and pruritus in chronic liver disease: a controlled study","volume":"54","author":"Jones","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:DDAS.0000011827.87103.2e","article-title":"A pilot study of etanercept in the treatment of primary sclerosing cholangitis","volume":"49","author":"Epstein","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.2006.03223.x","article-title":"An open study of modafinil for the treatment of daytime solomnence and fatigue in primary biliary cirrhosis","volume":"25","author":"Jones","year":"2007","journal-title":"Aliment Pharmocol Ther"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0168-8278(98)80253-5","article-title":"Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression","volume":"29","author":"Angulo","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB137|cit137","first-page":"1462","article-title":"Bone disease in liver transplant recipients: incidence, timing, and risk factors","volume":"23","author":"Porayko","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","article-title":"Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment","volume":"12","author":"Pares","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB139|cit139","first-page":"471","article-title":"Transdermal hormone replacement therapy imporves vertebral bone density in primary biliary cirrhosis: results of a one year controlled trial","volume":"25","author":"Pereira","year":"2007","journal-title":"Aliment Pharmacol Therap"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02258391","article-title":"Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study","volume":"40","author":"Lundqvist","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":"Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis","volume":"38","author":"Penna","year":"1996","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0016-5085(86)90926-1","article-title":"Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis","volume":"90","author":"Wiesner","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/00365528009181516","article-title":"Sclerosing cholangitis in ulcerative colitis","volume":"15","author":"Schrumpf","year":"1980","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primsary sclerosing cholangitis in ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.1840110103","article-title":"Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects","volume":"11","author":"Rabinovitz","year":"1990","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB153|cit153","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0959-8049(95)00216-6","article-title":"Role of bile acids in colorectal carcinogenesis","volume":"31","author":"Naggengast","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1572-0241.1999.01156.x","article-title":"The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis","volume":"94","author":"Shetty","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB156|cit156","article-title":"The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis","volume":"92","author":"Marchesa","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.510270308","article-title":"Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation","volume":"27","author":"Loftus","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/ibd.20204","article-title":"Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis","volume":"13","author":"Kaplan","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB160|cit160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/pgmj.2007.064592","article-title":"Chemoprevention and screening in primary sclerosing cholangitis","volume":"84","author":"Kitiyakara","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10350-004-7291-9","article-title":"Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"46","author":"MacLean","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB162|cit162","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2006-933565","article-title":"Liver transplantation in primary sclerosing cholangitis","volume":"26","author":"Bj\u00f8ro","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/jlts.2001.25879","article-title":"MELD and PELD: application of survival models to liver allocation","volume":"7","author":"Wiesner","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1600-6143.2006.01321.x","article-title":"Waiting list removal rates among patients with chronic and malignant liver diseases","volume":"6","author":"Freeman","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.2007.131730","article-title":"Selection of patients for liver transplantation and allocation of donated livers in the UK","volume":"57","author":"Neuberger","year":"2008","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1080\/00365520310006009","article-title":"Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries","volume":"38","author":"Brandsaeter","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB168|cit168","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/lt.20137","article-title":"Survival after liver transplantation in the United states: a disease specific analysis of the UNOS database","volume":"10","author":"Roberts","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB169|cit169","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB170|cit170","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB171|cit171","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1478-3231.2006.01395.x","article-title":"Recurrence of primary sclerosing cholangitis after living donor transplantation","volume":"27","author":"Tamura","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB172|cit172","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000144653","article-title":"Biliary tract complications after liver transplantation: a review","volume":"25","author":"Wojcicki","year":"2008","journal-title":"Dig Surg"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB173|cit173","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB174|cit174","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop","volume":"44","author":"La Russo","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB175|cit175","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: a double blind placebo controlled trial","volume":"16","author":"Lo","year":"1992","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB176|cit176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","article-title":"Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period","volume":"20","author":"Stiehl","year":"1994","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB177|cit177","unstructured":"De Maria N Colantoni A Rosenbloom E Van Thiel DH Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2\u2003year period. Hepatogastroenterology 1996 43 1472 9"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB178|cit178","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-8278(98)80059-7","article-title":"Ursodeoxycholic acid therapy for primary sclersosing cholangitis: results of a 2\u2003year randomised controlled trial to evaluate single vs. multiple daily disease","volume":"29","author":"Van Hoogstraten","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB179|cit179","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB180|cit180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1590-8658(03)00076-8","article-title":"Treatment of primary sclerosing cholangitis with low dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey","volume":"35","author":"Okolicsanyi","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB181|cit181","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB182|cit182","article-title":"Treatment of primary sclerosing cholangitis with oral methotrexate","volume":"86","author":"Knox","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB183|cit183","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","article-title":"A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis","volume":"106","author":"Knox","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB184|cit184","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/gut.34.2.242","article-title":"Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin","volume":"34","author":"Sandborn","year":"1993","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB185|cit185","first-page":"455","article-title":"Tacrolimus (FK506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB186|cit186","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(95)90220-1","article-title":"Colchicine treatment of primary sclerosing cholangitis","volume":"108","author":"Olsson","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB187|cit187","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0016-5085(88)90180-1","article-title":"Prospective trial of penicillamine in primary sclerosing cholangitis","volume":"95","author":"LaRusso","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB188|cit188","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","article-title":"A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis","volume":"95","author":"Bharucha","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB189|cit189","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-200012000-00005","article-title":"An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis","volume":"31","author":"Duchini","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB190|cit190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1013240225965","article-title":"Pirfenidone in the treatment of primary sclerosing cholangitis","volume":"47","author":"Angulo","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB191|cit191","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1023\/A:1026673811278","article-title":"Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study","volume":"44","author":"Angulo","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB192|cit192","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00042737-200102000-00013","article-title":"No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study","volume":"13","author":"Vleggaar","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB193|cit193","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1572-0241.2005.40484.x","article-title":"Mycophenolate mofetil for the treatment of primary sclerosing cholangitis","volume":"100","author":"Talwalkar","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB194|cit194","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis","volume":"27","author":"Talwalkar","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB195|cit195","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCG.0b013e3181662426","article-title":"A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis","volume":"42","author":"Hommes","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB196|cit196","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s10620-007-0052-6","article-title":"Silmarin in the treatment of patients with primary sclerosing cholangitis: an open label pilot study","volume":"53","author":"Angulo","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB197|cit197","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00535-010-0204-x","article-title":"Bezafibrate for the treatment of primary sclerosing cholangitis","volume":"45","author":"Mizuno","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB198|cit198","article-title":"The combination of prednisone and colchicine in patients with primary sclerosing cholangitis","volume":"86","author":"Lindor","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB199|cit199","article-title":"Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid","volume":"41","author":"Kyokane","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB200|cit200","article-title":"Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study","volume":"91","author":"Lindor","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB201|cit201","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-131-12-199912210-00006","article-title":"Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis","volume":"131","author":"Schramm","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB202|cit202","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9270(00)01059-5","article-title":"Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group","volume":"95","author":"van Hoogstraten","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB203|cit203","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2004.02214.x","article-title":"A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis","volume":"20","author":"Sterling","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB204|cit204","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","volume":"47","author":"Davies","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB205|cit205","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04658.x-BIB206|cit206","doi-asserted-by":"crossref","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04658.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04658.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:11:30Z","timestamp":1741147890000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2011.04658.x"}},"subtitle":["Systematic review: management of primary sclerosing cholangitis"],"short-title":[],"issued":{"date-parts":[[2011,4,18]]},"references-count":206,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04658.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,18]]}}}